Discover this podcast and so much more

Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

111. Highlights from the SPD! - Ritlecitinib in adolescents with alopecia areata - UBA1 Variants Associated With VEXAS Syndrome - Role of Soluble IL-2 Receptor in Health & Disease - Botox for HA

111. Highlights from the SPD! - Ritlecitinib in adolescents with alopecia areata - UBA1 Variants Associated With VEXAS Syndrome - Role of Soluble IL-2…

FromDermasphere - The Dermatology Podcast


111. Highlights from the SPD! - Ritlecitinib in adolescents with alopecia areata - UBA1 Variants Associated With VEXAS Syndrome - Role of Soluble IL-2…

FromDermasphere - The Dermatology Podcast

ratings:
Length:
75 minutes
Released:
Aug 7, 2023
Format:
Podcast episode

Description

Highlights from the SPD! -
Ritlecitinib in adolescents with alopecia areata -
UBA1 Variants Associated With VEXAS Syndrome -
Role of Soluble IL-2 Receptor in Health & Disease -
Botox Type B for Hidradenitis Supperativa -
Check out our video content on VuMedi!: https://www.vumedi.com/channel/dermasphere/
Luke's PDPC course and the Intermountain Derm Society meeting: ⁠⁠⁠https://registration.socio.events/e/idspdpc23/promo-codes/ATTENDEE⁠⁠
The University of Utah's Dermatology ECHO: ⁠⁠https://physicians.utah.edu/echo/dermatology-primarycare⁠⁠Connect with us!
- Web: ⁠https://dermaspherepodcast.com/⁠
- Twitter: @DermaspherePC
- Instagram: dermaspherepodcast
- Facebook: https://www.facebook.com/DermaspherePodcast/
- Check out Luke and Michelle’s other podcast, SkinCast! ⁠https://healthcare.utah.edu/dermatology/skincast/⁠
Luke and Michelle report no significant conflicts of interest… BUT check out our friends at:
- ⁠Kikoxp.com⁠(a social platform for doctors to share knowledge)
- ⁠https://www.levelex.com/games/top-derm⁠ (A free dermatology game to learn more dermatology!)
Released:
Aug 7, 2023
Format:
Podcast episode

Titles in the series (100)

For dermatology practitioners, Dermasphere covers the most important updates from the latest articles and research in the field. Maybe you don’t have time to read the journals—but we hope you have time to listen to a podcast about them!